Document:

EX-4.1

 EXHIBIT 4.1 

SPECIMEN COMMON STOCK CERTIFICATE 

[specimen common stock certificate] 

Incorporated under the Laws of the State of North Carolina 

Number of Shares of Common Stock:
                     of Live Oak Bancshares, Inc. no par value per share. 

This Common Stock of Live Oak Bancshares, Inc. is transferable only on the books of the Corporation by the holder hereof in person or by Attorney upon
surrender of this Certificate properly endorsed. 
 IN WITNESS WHEREOF, the said Corporation has caused this Certificate to be signed by its duly authorized
officers and its Corporate Seal to be hereunto affixed this                  day of
                            , 2014. 

 

							
	President						Secretary

-  -  -  -  -  -  -  -  -  -  -  
-  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  
-  -  -  -  -  -  -  -  -  -  -  -  -  -  -  - 

Certificate Number:                      for
                     Shares of Common Stock 

For Value Received,                      hereby
sell, assign, and transfer unto                      Shares of the Common Stock represented by the within Certificate, said Common Stock on
the books of the within named Corporation with full power of substitution in the premises. 
 Dated:
                            , 2014.EX-4.2

 Exhibit 4.2 

REGISTRATION AND OTHER RIGHTS AGREEMENT 

 TABLE OF CONTENTS 
  

									
	 	  	 	  	 	  	Page	 
			
	1.	  	Definitions	  	 	1	  
			
	2.	  	Registration Rights	  	 	5	  
		  	2.1	  	SEC Reporting Company; Demand Registration	  	 	5	  
		  	2.2	  	Company Registration	  	 	7	  
		  	2.3	  	Underwriting Requirements	  	 	7	  
		  	2.4	  	Obligations of the Company	  	 	8	  
		  	2.5	  	Furnish Information	  	 	10	  
		  	2.6	  	Expenses of Registration	  	 	10	  
		  	2.7	  	Delay of Registration	  	 	10	  
		  	2.8	  	Indemnification	  	 	10	  
		  	2.9	  	Reports Under Exchange Act	  	 	13	  
		  	2.10	  	Limitations on Subsequent Registration Rights	  	 	13	  
		  	2.11	  	“Market Stand-off” Agreement	  	 	14	  
		  	2.12	  	Restrictions on Transfer	  	 	14	  
		  	2.13	  	Termination of Registration Rights	  	 	16	  
			
	3.	  	Information and Observer Rights	  	 	16	  
		  	3.1	  	Delivery of Financial Statements	  	 	16	  
		  	3.2	  	Inspection	  	 	17	  
		  	3.3	  	Observer Rights	  	 	18	  
		  	3.4	  	Termination of Information and Observer Rights	  	 	18	  
		  	3.5	  	Confidentiality	  	 	18	  
			
	4.	  	Rights to Future Stock Issuances	  	 	19	  
		  	4.1	  	Right of Participation	  	 	19	  
		  	4.2	  	Termination	  	 	20	  
			
	5.	  	Additional Covenants	  	 	21	  
		  	5.1	  	Insurance	  	 	21	  
		  	5.2	  	Employee Agreements	  	 	21	  
		  	5.3	  	Matters Requiring Approval of the Independent Directors	  	 	21	  
		  	5.4	  	Board Matters	  	 	21	  
		  	5.5	  	Successor Indemnification	  	 	22	  
		  	5.6	  	FCPA	  	 	22	  
		  	5.7	  	Termination of Covenants	  	 	22	  
			
	6.	  	Miscellaneous	  	 	23	  
		  	6.1	  	Successors and Assigns	  	 	23	  
		  	6.2	  	Governing Law	  	 	23	  
		  	6.3	  	Counterparts	  	 	24	  
		  	6.4	  	Titles and Subtitles	  	 	24	  

  
 i 

									
			6.5		Notices		 	24	  
			6.6		Amendments and Waivers		 	24	  
			6.7		Severability		 	25	  
			6.8		Aggregation of Stock		 	25	  
			6.9		Entire Agreement		 	25	  
			6.10		Dispute Resolution		 	25	  
			6.11		Delays or Omissions		 	26	  
			6.12		Acknowledgment		 	26	  
		
	Schedule A - Schedule of Investors				

  
 ii 

 REGISTRATION AND OTHER RIGHTS AGREEMENT 

THIS REGISTRATION AND OTHER RIGHTS AGREEMENT (this “Agreement”), is made as of the 5th day of August, 2014, by and among Live
Oak Bancshares, Inc., a North Carolina corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”. 

RECITALS 

WHEREAS, the Company and the Investors are parties to the Securities Purchase Agreement, dated as of May 28, 2014 (the
“Purchase Agreement”); and 
 WHEREAS, in order to induce the Company to enter into the Purchase Agreement and to
induce the Investors to invest funds in the Company pursuant to the Purchase Agreement, the Investors and the Company hereby agree that this Agreement shall govern the rights of the Investors to cause the Company to register shares of Common Stock
issuable to the Investors, to receive certain information from the Company, and to participate in future equity offerings by the Company, and shall govern certain other matters as set forth in this Agreement; 

NOW, THEREFORE, the parties hereby agree as follows: 

1. Definitions. For purposes of this Agreement: 

1.1 “Affiliate” means, with respect to any specified Person, any other Person who, directly or indirectly,
controls, is controlled by, or is under common control with such Person, including without limitation any general partner, managing member, officer or director of such Person or any venture capital fund or other entity now or hereafter existing that
is controlled by one or more general partners or managing members of, or shares the same management company or investment adviser with, such Person. 

1.2 “Bank” means Live Oak Banking Company, a North Carolina state nonmember bank and a wholly-owned subsidiary
of the Company. 
 1.3 “Common Stock” means the Voting Common Stock and the Non-Voting Common Stock. 

1.4 “Competitor” means a Person engaged, directly or indirectly (including through any partnership, limited
liability company, corporation, joint venture or similar arrangement (whether now existing or formed hereafter)), in a business that competes with any business of the Company and/or its subsidiaries as reasonably determined in good faith by the
Board of Directors; provided, however, that any venture capital firm, institutional investor, financial investment firm or collective investment vehicle that is in the business of investing in entities (or any employee, partner or member of such an
entity) shall under no circumstances be deemed a “Competitor” solely as a result of such entity’s investments in such a business. 

1.5 “Damage” means any loss, damage, claim or liability (joint or several) to which a party hereto may become
subject under the Securities Act, the 

  
 1 

 Exchange Act, or other federal or state law, insofar as such loss, damage, claim
or liability (or any action in respect thereof) arises out of or is based upon: (i) any untrue statement or alleged untrue statement of a material fact contained in any registration statement of the Company, including any preliminary prospectus
or final prospectus contained therein or any amendments or supplements thereto; (ii) an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or
(iii) any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the
Exchange Act, or any state securities law. 
 1.6 “Derivative Securities” means any securities or rights
convertible into, or exercisable or exchangeable for (in each case, directly or indirectly), Common Stock, including options and warrants. 

1.7 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder. 
 1.8 “Excluded Registration” means (i) a registration relating to the sale of
securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (ii) a registration relating to an SEC Rule 145 transaction; (iii) a registration on any form that does not include
substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or (iv) a registration in which the only Common Stock being registered is Common Stock issuable
upon conversion of debt securities that are also being registered. 
 1.9 “Exempted Securities” means the
following: (i) shares of Common Stock or Derivative Securities issued by reason of a dividend, stock split, split-up or other distribution on shares of Common Stock; (ii) shares of Common Stock or
options to purchase Common Stock issued to employees or directors of, or consultants or advisors to, the Company or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board of Directors of the Company, subject to
Subsection 5.4; (iii) shares of Common Stock or Derivative Securities actually issued upon the exercise, conversion or exchange of Derivative Securities, in each case provided such issuance is pursuant to the terms of such
Derivative Security; and (iv) shares of Common Stock issued by the Company as consideration for the acquisition of another entity. 

1.10 “Form S-1” means such form under the Securities Act as in effect on the date hereof or any successor
registration form under the Securities Act subsequently adopted by the SEC. 
 1.11 “Form S-3” means
such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC that permits incorporation of substantial information by reference to other documents filed by the
Company with the SEC. 

  
 2 

 1.12 “GAAP” means generally accepted accounting principles in
the United States. 
 1.13 “Holder” means any holder of Registrable Securities who is a party to this
Agreement. 
 1.14 “Immediate Family Member” means a child, stepchild, grandchild, parent, stepparent,
grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including, adoptive relationships, of a natural person referred to herein. 

1.15 “Initiating Holders” means, collectively, Holders who properly initiate a registration request under this
Agreement. 
 1.16 “IPO” means the Company’s first underwritten public offering of its Voting Common
Stock under the Securities Act. 
 1.17 “National Stock Exchange” means The NASDAQ Global Market, The NASDAQ
Global Select Market, The NASDAQ Capital Market, the New York Stock Exchange or the NYSE MKT. 
 1.18 “New
Securities” means, collectively, equity securities of the Company, whether or not currently authorized, as well as rights, options, or warrants to purchase such equity securities, or securities of any type whatsoever that are, or may
become, convertible or exchangeable into or exercisable for such equity securities. 
 1.19 “Non-Management
Directors” shall have the meaning set forth in the Significant Shareholders Agreement. 
 1.20 “Non-Voting
Common Stock” means shares of the Company’s non-voting common stock, no par value per share, and also includes any securities into which the Non-Voting Common Stock may hereinafter be converted, reclassified or changed. 

1.21 “Person” means any individual, corporation, partnership, trust, limited liability company, association or
other entity. 
 1.22 “Proceeding” means an action, claim, suit, investigation or proceeding (including,
without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or threatened. 
 1.23
“Registrable Securities” means (i) any Common Stock held by the Investors or their permitted transferees; and (ii) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other
security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares referenced in clause (i) above; excluding in all cases, however, any Registrable Securities sold by a Person in
a transaction in which the applicable rights 

  
 3 

 
under this Agreement are not assigned pursuant to Subsection 6.1, and excluding for purposes of Section 2 any shares for which registration rights have terminated pursuant to
Subsection 2.13 of this Agreement. 
 1.24 “Registrable Securities then outstanding” means the number
of shares determined by adding the number of shares of outstanding Common Stock that are Registrable Securities and the number of shares of Common Stock issuable (directly or indirectly) pursuant to then exercisable and/or convertible securities
that are Registrable Securities. 
 1.25 “Restricted Securities” means the securities of the Company
required to be notated with the legend set forth in Subsection 2.12(b) hereof. 
 1.26 “Sale of the
Company” shall mean either: (i) a transaction or series of related transactions in which a Person, or a group of related Persons, acquires from shareholders of the Company shares representing more than fifty percent (50%) of the
outstanding voting power of the Company or more than fifty percent (50%) of the total equity of the Company; (ii) a merger or consolidation in which (A) the Company is a constituent party or (B) a subsidiary of the Company is a
constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of capital stock of the Company
outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting
power, of the capital stock of (1) the surviving or resulting corporation or (2) if the surviving or resulting corporation is a wholly owned subsidiary of another corporation immediately following such merger or consolidation, the parent
corporation of such surviving or resulting corporation; or (iii) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of
all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger, consolidation or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the
Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company. 

1.27 “SEC” means the Securities and Exchange Commission. 

1.28 “SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act. 

1.29 “SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities Act. 

1.30 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated
thereunder. 

  
 4 

 1.31 “Selling Expenses” means all underwriting discounts,
selling commissions, and stock transfer taxes applicable to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by the Company
as provided in Subsection 2.6. 
 1 .32 “Significant Shareholders Agreement” means that certain
Significant Shareholders Agreement, dated as of the date hereof, by and among the Company, the Investors, and certain other shareholders of the Company, as amended from time to time. 

1.33 “Voting Common Stock” means shares of the Company’s voting common stock, no par value per share, and
also includes any securities into which the Voting Common Stock may hereinafter be converted, reclassified or changed. 
 2. Registration
Rights. The Company covenants and agrees as follows: 
 2.1 SEC Reporting Company; Demand Registration. 

(a) SEC Reporting Company. By no later than the fifth anniversary of the Closing (as defined in the Purchase Agreement), the Company
shall cause itself (i) to be subject to the periodic reporting requirements of Section 13 (by having its Voting Common Stock registered under Section 12 of the Exchange Act) or Section 15(d) of the Exchange Act and (ii) to have
its Voting Common Stock listed on a National Stock Exchange. 
 (b) Form S-1 Demand. If at any time after the earlier of (i) one
hundred eighty (180) days after the effective date of the registration statement for the IPO or (ii) the date the Company becomes subject to the periodic reporting requirements of Section 13 or Section 15(d) of the Exchange Act, the Company receives
a request from Holders of at least a majority of the Registrable Securities then outstanding that the Company file a Form S-1 registration statement covering the registration of Registrable Securities with an anticipated aggregate offering price of
at least $5.0 million, then the Company shall (x) within ten (10) days after the date such request is given, give notice thereof (the “Demand Notice”) to all Holders other than the Initiating Holders; and (y) as soon as practicable, and in
any event within ninety (90) days after the date such request is given by the Initiating Holders, file a Form S-1 registration statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be
registered and any additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given,
and in each case, subject to the limitations of Subsections 2.1(d) and 2.3. 
 (c) Form S-3 Demand. If at any time
when it is eligible to use a Form S-3 registration statement, the Company receives a request from Holders of at least a majority of the Registrable Securities then outstanding that the Company file a Form S-3 registration statement with respect to
outstanding Registrable Securities of such Holders having an anticipated aggregate offering price of at least $1.0 million, then the Company shall (i) within ten (10) days after the date such request is given, give a Demand Notice to all Holders
other than the 

  
 5 

 
Initiating Holders; and (ii) as soon as practicable, and in any event within sixty (60) days after the date such request is given by the Initiating Holders, file a Form S-3 registration statement
under the Securities Act covering all Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand
Notice is given, and in each case, subject to the limitations of Subsections 2.1(d) and 2.3. 
 (d) Notwithstanding the
foregoing obligations, if the Company furnishes to Holders requesting a registration pursuant to Subsection 2.l(b) or Subsection 2.l(c) a certificate signed by the Company’s chief executive officer stating that in the good faith
judgment of the Company’s Board of Directors it would be materially detrimental to the Company and its shareholders for such registration statement to be filed and it is therefore necessary to defer the filing of such registration statement,
then the Company shall have the right to defer taking action with respect to such filing for a period of not more than sixty (60) days after the request of the Initiating Holders is given; provided, however, that the Company may not
invoke this right more than once in any twelve (12) month period; and provided further that the Company shall not register any securities for its own account or that of any other shareholder during such sixty (60) day period
other than pursuant to (A) a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (B) a registration on any form that does not include
substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or (C) a registration in which the only Common Stock being registered is Common Stock issuable
upon conversion of debt securities that are also being registered. 
 (e) The Company shall not be obligated to effect, or to take any
action to effect, any registration pursuant to Subsection 2.1(b) during the period that is sixty (60) days before the Company’s good faith estimate of the date of filing of, and ending on a date that is one hundred eighty
(180) days after the effective date of, a Company-initiated registration, provided that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective;
(ii) after the Company has effected two registrations pursuant to Subsection 2.1(b); or (iii) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on Form S-3 pursuant
to a request made pursuant to Subsection 2.1(c). The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Subsection 2.1(c) (i) during the period that is thirty (30) days
before the Company’s good faith estimate of the date of filing of, and ending on a date that is ninety (90) days after the effective date of, a Company-initiated registration, provided that the Company is actively employing in good
faith commercially reasonable efforts to cause such registration statement to become effective; or (ii) if the Company has effected two registrations pursuant to Subsection 2.l(c) within the twelve (12) month period immediately
preceding the date of such request. A registration shall not be counted as “effected” for purposes of this Subsection 2.1(e). until such time as the applicable registration statement has been declared effective by the SEC, unless
the Initiating Holders withdraw their request for such registration, elect not to pay the registration expenses therefor, and forfeit their right to one demand registration statement pursuant to Subsection 2.6, in which case such withdrawn
registration statement shall be counted as “ effected” for this Subsection 2.1(e). 

  
 6 

 2.2 Company Registration. If the Company proposes to register (including, for this
purpose, a registration effected by the Company for shareholders other than the Holders) any of its securities under the Securities Act in connection with the public offering of such securities solely for cash (other than in an Excluded
Registration), including, without limitation, pursuant to the Company’s obligations under Subsection 2.1(a), the Company shall, at such time, promptly give each Holder notice of such registration. Upon the request of each Holder given
within twenty (20) days after such notice is given by the Company, the Company shall, subject to the provisions of Subsection 2.3, cause to be registered all of the Registrable Securities that each such Holder has requested to be
included in such registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Subsection 2.2 before the effective date of such registration, whether or not any Holder has elected to
include Registrable Securities in such registration. The expenses (other than Selling Expenses) of such withdrawn registration shall be borne by the Company in accordance with Subsection 2.6. 

2.3 Underwriting Requirements. 

(a) If, pursuant to Subsection 2.1, the Initiating Holders intend to distribute the Registrable Securities covered by their request by
means of an underwriting, they shall so advise the Company as a part of their request made pursuant to Subsection 2.1, and the Company shall include such information in the Demand Notice. The underwriter(s) will be selected by the Initiating
Holders holding at least a majority of the Registrable Securities covered by the request made pursuant to Subsection 2.1, subject to approval of the Company. In such event, the right of any Holder to include such Holder’s Registrable
Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing
to distribute their securities through such underwriting shall (together with the Company as provided in Subsection 2.4(e)) enter into an underwriting agreement in customary form with the underwriter(s) selected for such underwriting.
Notwithstanding any other provision of this Subsection 2.3, if the managing underwriter(s) advise(s) the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the Initiating
Holders shall so advise all Holders of Registrable Securities that otherwise would be underwritten pursuant hereto, and the number of Registrable Securities and any other securities that may be included in the underwriting shall be allocated among
such Holders of Registrable Securities, including the Initiating Holders, and any other selling shareholders, in proportion (as nearly as practicable) to the sum of (i) the number of Registrable Securities owned by each Holder and (ii) the
number of other securities owned by each other selling shareholder, or in such other proportion as shall mutually be agreed to by all such selling Holders and such other selling shareholders. 

(b) In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant to Subsection
2.1(a) or Subsection 2.2, the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the Holders accept the terms of the underwriting as agreed upon between the Company and its
underwriters, and then only in such quantity as the underwriters in their sole discretion determine will not jeopardize the success of the offering by the Company. If the total 

  
 7 

 
number of securities, including Registrable Securities, requested by shareholders to be included in such offering exceeds the number of securities to be sold (other than by the Company) that the
underwriters in their reasonable discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the
underwriters and the Company in their sole discretion determine will not jeopardize the success of the offering. If the underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such
offering, then the Registrable Securities and any other securities that are included in such offering shall be allocated among the selling Holders and any other selling shareholders in proportion (as nearly as practicable) to the sum of (i) the
number of Registrable Securities owned by each selling Holder and (ii) the number of other securities owned by each other selling shareholder, or in such other proportions as shall mutually be agreed to by all such selling Holders and such
other selling shareholders. Notwithstanding the foregoing, in no event shall the number of Registrable Securities included in the offering be reduced below thirty percent (30%) of the total number of securities included in such offering, unless
such offering is the IPO, in which case the selling Holders may be excluded further (on a pro rata basis with any other selling shareholders, consistent with the immediately preceding sentence) if the underwriters make the determination described
above. For purposes of the provision in this Subsection 2.3(b) concerning apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the partners, members, retired partners, retired members,
shareholders, and Affiliates of such Holder, or the estates and Immediate Family Members of any such partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing Persons, shall be deemed to be a
single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate number of Registrable Securities owned by all Persons included in such “selling Holder,” as
defined in this sentence. 
 (c) For purposes of Subsection 2.1, a registration shall not be counted as “effected” if, as
a result of an exercise of the underwriter’s cutback provisions in Subsection 2.3(a), fewer than fifty percent (50%) of the total number of Registrable Securities that Holders have requested to be included in such registration
statement are actually included. 
 2.4 Obligations of the Company. Whenever required under this Section 2 to effect the
registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) prepare and file with the
SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such registration statement to become effective and, upon the request of the Holders of a majority of the Registrable
Securities registered thereunder, keep such registration statement effective for a period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed;
provided, however, that (i) such one hundred twenty (120) day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of Common Stock (or other securities) of
the Company, from selling any securities included in such registration, and (ii) in the case of any registration of Registrable Securities on Form S-3 that are intended to be offered on a continuous or delayed 

  
 8 

 
basis, subject to compliance with applicable SEC rules, such one hundred twenty (120) day period shall be extended for up to 60 days, if necessary, to keep the registration statement
effective until all such Registrable Securities are sold; 
 (b) prepare and file with the SEC such amendments and supplements to such
registration statement, and the prospectus used in connection with such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such registration statement; 

(c) furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, as required by the Securities
Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; 

(d) use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other
securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company shall not be required to qualify to do business or to file a general consent to service of process in any
such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

(e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the underwriter(s) of such offering; 
 (f) use its commercially reasonable efforts to cause all such Registrable
Securities covered by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed; 

(g) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number
for all such Registrable Securities, in each case not later than the effective date of such registration; 
 (h) promptly make available
for inspection by the selling Holders, any underwriter(s) participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders,
all customary financial and other records, pertinent corporate documents, and properties of the Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all information reasonably requested by any
such seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith; 

(i) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has been
declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and 

  
 9 

 (j) after such registration statement becomes effective, notify each selling Holder of any
request by the SEC that the Company amend or supplement such registration statement or prospectus. 
 In addition, the Company shall ensure
that, at all times after any registration statement covering a public offering of securities of the Company under the Securities Act shall have become effective, its insider trading policy shall provide that the Company’s directors may
implement a trading program under Rule 10b5-1 of the Exchange Act. 
 2.5 Furnish Information. It shall be a condition precedent to
the obligations of the Company to take any action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the
Registrable Securities held by it, and the intended method of disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable Securities. 

2.6 Expenses of Registration. All expenses (other than Selling Expenses) incurred in connection with registrations, filings, or
qualifications pursuant to Section 2, including all registration, filing, and qualification fees; printers’ and accounting fees; fees and disbursements of counsel for the Company; and the reasonable fees and disbursements, not to exceed
$20,000, of one counsel for the selling Holders (“Selling Holder Counsel”), shall be borne and paid by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration
proceeding begun pursuant to Subsection 2.1 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all selling Holders shall bear such
expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one registration pursuant to
Subsections 2.l(b) or 2.l(c), as the case may be; provided further that if, at the time of such withdrawal, the Holders shall have learned of a material adverse change in the condition, business, or prospects of the
Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness after learning of such information then the Holders shall not be required to pay any of such expenses and shall not forfeit
their right to one registration pursuant to Subsections 2.1(b) or 2.1(c). All Selling Expenses relating to Registrable Securities registered pursuant to this Section 2 shall be borne and paid by the Holders pro rata on the basis
of the number of Registrable Securities registered on their behalf. 
 2.7 Delay of Registration. No Holder shall have any right to
obtain or seek an injunction restraining or otherwise delaying any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.8 Indemnification. If any Registrable Securities are included in a registration statement under this Section 2: 

  
 10 

 (a) To the extent permitted by law, the Company will indemnify and hold harmless each selling
Holder, and the partners, members, officers, directors, and shareholders of each such Holder; legal counsel, investment advisers and accountants for each such Holder; any underwriter (as defined in the Securities Act) for each such Holder; and each
Person, if any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or other aforementioned Person
any legal or other expenses reasonably incurred thereby in connection with investigating or defending any Proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement
contained in this Subsection 2.8(a) shall not apply to amounts paid in settlement of any such Proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the
Company be liable for any Damages to the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of any such Holder, underwriter, controlling
Person, or other aforementioned Person expressly for use in connection with such registration. 
 (b) To the extent permitted by law, each
selling Holder, severally and not jointly, will indemnify and hold harmless the Company, and each of its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of
the Securities Act, legal counsel and accountants for the Company, any underwriter (as defined in the Securities Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other
Holder, against any Damages, in each case only to the extent that such Damages arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder
expressly for use in connection with such registration; and each such selling Holder will pay to the Company and each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending
any Proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Subsection 2.8(b) shall not apply to amounts paid in settlement of any such
Proceeding if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; and provided further that in no event shall the aggregate amounts payable by any Holder by way of indemnity
or contribution under Subsections 2.8(b) and 2.8(d) exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of fraud or willful misconduct by such Holder. 

(c) Promptly after receipt by an indemnified party under this Subsection 2.8 of notice of the commencement of any action (including
any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Subsection 2.8, give the indemnifying
party notice of the commencement thereof. The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly with any other indemnifying party to which notice has been
given, and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified 

  
 11 

 
parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if
representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such
action. The failure to give notice to the indemnifying party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of any liability to the indemnified party under this Subsection 2.8, to the
extent that such failure materially prejudices the indemnifying party’s ability to defend such action. The failure to give notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise
than under this Subsection 2.8. 
 (d) To provide for just and equitable contribution to joint liability under the Securities Act in
any case in which either: (i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Subsection 2.8 but it is judicially determined (by the entry of a final judgment or decree by a
court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this Subsection 2.8 provides for
indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided under this Subsection 2.8, then, and in each such case, such parties will
contribute to the aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the
indemnified party in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other relevant equitable considerations. The relative fault of the
indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to
information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; provided, however,
that, in any such case (x) no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement, and (y) no
Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation; and provided further
that in no event shall a Holder’s liability pursuant to this Subsection 2.8(d), when combined with the amounts paid or payable by such Holder pursuant to Subsection 2.8(b), exceed the proceeds from the offering received by such
Holder (net of any Selling Expenses paid by such Holder), except in the case of willful misconduct or fraud by such Holder. 
 (e)
Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing
provisions, the provisions in the underwriting agreement shall control. 

  
 12 

 (f) Unless otherwise superseded by an underwriting agreement entered into in connection with the
underwritten public offering, the obligations of the Company and Holders under this Subsection 2.8 shall survive the completion of any offering of Registrable Securities in a registration under this Section 2, and otherwise shall
survive the termination of this Agreement. 
 2.9 Reports Under Exchange Act. With a view to making available to the Holders the
benefits of SEC Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company shall: 

(a) Until such time as SEC Rule 144 or another similar exemption under the Securities Act is available for the sale of all of such
Holder’s shares of Common Stock without limitation during a three month period without registration and without the requirement for the Company to be in compliance with the current public information required under SEC Rule 144(c)(l), make and
keep available adequate current public information, as those terms are understood and defined in SEC Rule 144, at all times after the earlier of (i) the effective date of the registration statement filed by the Company for the IPO and
(ii) the date the Company becomes subject to the periodic reporting requirements of Section 13 or Section 15(d) of the Exchange Act; 

(b) Until such time as SEC Rule 144 or another similar exemption under the Securities Act is available for the sale of all of such
Holder’s shares of Common Stock without limitation during a three month period without registration and without the requirement for the Company to be in compliance with the current public information required under SEC Rule 144(c)(1), use
commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting
requirements); and 
 (c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) to
the extent accurate, a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the registration statement filed by the Company for the
IPO), the Securities Act, and the Exchange Act (at any time after the Company has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after the Company
so qualifies); and (ii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration (at any time after the Company has
become subject to the reporting requirements under the Exchange Act) or pursuant to Form S-3 (at any time after the Company so qualifies to use such form). 

2.10 Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without the
prior written consent of the Holders of a majority of the Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company that would provide to such holder the right to include
securities in any registration statement on other than either a pro rata basis 

  
 13 

 
with respect to the Registrable Securities or on a subordinate basis after all Holders have had the opportunity to include in the registration statement and offering all shares of Registrable
Securities that they wish to include. 
 2.11 “Market Stand-off” Agreement. Each Holder hereby agrees that it will not,
without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the IPO, and ending on the date specified by the Company and the managing underwriter (such period not to
exceed one hundred eighty (180) days), (i) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase; or otherwise
transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Common Stock, in each case, held immediately before the effective date of the
registration statement for such offering or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described
in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash, or otherwise. The foregoing provisions of this Subsection 2.11 shall not apply to the sale of any shares to an underwriter
pursuant to an underwriting agreement, or the transfer of any shares to any trust for the direct or indirect benefit of the Holder or the immediate family of the Holder, provided that the trustee of the trust agrees to be bound in writing by the
restrictions set forth herein, and provided further that any such transfer shall not involve a disposition for value, and shall be applicable to the Holders only if all officers and directors and all shareholders individually owning five percent
(5%) or more of the Company’s outstanding Common Stock are subject to the same restrictions. The underwriters in connection with such registration are intended third-party beneficiaries of this Subsection 2.11 and shall have the
right, power and authority to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration that are
consistent with this Subsection 2.11 or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to
all Holders subject to such agreements, based on the number of shares subject to such agreements. In addition, in the event that any percentage of the Common Stock or any security convertible into or exercisable or exchangeable for Common Stock held
by any officer, director or shareholder owning five percent (5%) or more of the Company’s outstanding Common Stock is released from any similar restrictions, the same percentage of the Common Stock or any security convertible into or
exercisable or exchangeable for Common Stock held by each Holder shall be immediately and fully released from any restrictions on transfer set forth herein concurrently therewith. 

2.12 Restrictions on Transfer. 

(a) The Registrable Securities shall not be sold, pledged, or otherwise transferred, and the Company shall not recognize and shall issue
stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon the conditions specified in this Agreement, which conditions are intended to ensure compliance with the provisions of the Securities
Act. A transferring Holder, other than with respect to a sale pursuant 

  
 14 

 
to an effective registration statement or SEC Rule 144, will cause any proposed purchaser, pledgee, or transferee of the Registrable Securities held by such Holder to agree to take and hold such
securities subject to the provisions and upon the conditions specified in this Agreement. 
 (b) Each certificate, instrument, or book
entry representing (i) the Registrable Securities and (ii) any other securities issued in respect of the securities referenced in clause (i), upon any stock split, stock dividend, recapitalization, merger, consolidation, or similar event,
shall (unless otherwise permitted by the provisions of Subsection 2.12(c)) be notated with a legend substantially in the following form: 

THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933. SUCH SHARES MAY NOT BE SOLD, PLEDGED, OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT. 

THE SECURITIES REPRESENTED HEREBY MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND
THE SHAREHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 
 The Holders consent to the Company making a notation in
its records and giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer set forth in this Subsection 2.12. 

(c) The holder of such Restricted Securities, by acceptance of ownership thereof, agrees to comply in all respects with the provisions of
this Section 2. Before any proposed sale, pledge, or transfer of any Restricted Securities, unless there is in effect a registration statement under the Securities Act covering the proposed transaction or the Registrable Securities are
being sold pursuant to SEC Rule 144, the Holder thereof shall give notice to the Company of such Holder’s intention to effect such sale, pledge, or transfer. Each such notice shall describe the manner and circumstances of the proposed sale,
pledge, or transfer in sufficient detail and, if reasonably requested by the Company, shall be accompanied at such Holder’s expense by either (i) a written opinion of legal counsel who shall, and whose legal opinion shall, be reasonably
satisfactory to the Company, addressed to the Company, to the effect that the proposed transaction may be effected without registration under the Securities Act; (ii) a “no action” letter from the SEC to the effect that the proposed
sale, pledge, or transfer of such Restricted Securities without registration will not result in a recommendation by the staff of the SEC that action be taken with respect thereto; or (iii) any other evidence reasonably satisfactory to counsel
to the Company to the effect that the proposed sale, pledge, or transfer of the Restricted Securities may be effected without registration under the Securities Act, whereupon the Holder of such Restricted Securities shall be entitled to sell,
pledge, or transfer such Restricted Securities in accordance with the terms of the notice given by the Holder to the Company. The Company will not require such a legal opinion or “no action” letter (x) in any transaction in compliance with
SEC Rule 144 (provided that the transferor provides the 

  
 15 

 
Company with reasonable assurances (in the form of a seller representation letter and, if applicable, a broker representation letter) that such securities may be sold pursuant to such rule); or
(y) in any transaction in which such Holder distributes Restricted Securities to an Affiliate of such Holder for no consideration; provided that, with respect to transfers under this clause (y), each transferee agrees in writing to be
subject to the terms of this Subsection 2.12. Each certificate, instrument, or book entry representing the Restricted Securities transferred as above provided shall be notated with, except if such transfer is made pursuant to an effective
registration statement or pursuant to SEC Rule 144, the appropriate restrictive legend set forth in Subsection 2.12(b), except that such certificate instrument, or book entry shall not be notated with such restrictive legend if, in the
opinion of counsel for such Holder and the Company, such legend is not required in order to establish compliance with any provisions of the Securities Act. 

2.13 Termination of Registration Rights. The right of any Holder to request registration or inclusion of Registrable Securities in any
registration pursuant to Subsections 2.1 or 2.2 shall terminate, with respect to any Voting Common Stock only, upon the earlier of (i) the fifth anniversary of the IPO and (ii) such time as SEC Rule 144 or another similar
exemption under the Securities Act is available for the sale of all of such Holder’s shares of Common Stock without limitation during a three month period without registration and without the requirement for the Company to be in compliance with
the current public information required under SEC Rule 144(c)(1). 
 3. Information and Observer Rights. 

3.1 Delivery of Financial Statements. For so long as an Investor continues to hold any Common Stock, the Company shall deliver to such
Investor, provided that the Board of Directors has not reasonably determined that such Investor is a Competitor: 
 (a) as soon as
practicable, but in any event within one hundred twenty (120) days after the end of each fiscal year of the Company (i) a balance sheet as of the end of such year, (ii) statements of income and of cash flows for such year, and a
comparison between (x) the actual amounts for such fiscal year and (y) the comparable amounts for the prior year, and (iii) a statement of shareholders’ equity as of the end of such year, all such financial statements audited and
certified by independent public accountants of nationally recognized standing selected by the Company and prepared in accordance with GAAP; 

(b) as soon as practicable, but in any event within forty-five (45) days after the end of each of the first three (3) quarters of
each fiscal year of the Company, unaudited statements of income and cash flows for such fiscal quarter, and an unaudited balance sheet and a statement of shareholders’ equity as of the end of such fiscal quarter, all prepared in accordance with
GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments; and (ii) not contain all notes thereto that may be required in accordance with GAAP); 

(c) as soon as practicable, but in any event within thirty (30) days of the end of each month, an unaudited income statement and
statement of cash flows for such month, and an unaudited balance sheet and statement of shareholders’ equity as of the end of 

  
 16 

 
such month, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments and (ii) not contain all notes thereto
that may be required in accordance with GAAP); 
 (d) as soon as practicable, but in any event thirty (30) days before the end of each
fiscal year, a budget for the next fiscal year (the “Budget”), approved by the Board of Directors and forecasting the Company’s revenues, expenses and cash position on a monthly basis; 

(e) as soon as practicable, but in any event within forty-five (45) days after the end of each of the first three (3) quarters of
each fiscal year of the Company, a statement showing the number of shares of each class and series of capital stock of the Company and securities convertible into or exercisable for shares of capital stock of the Company outstanding at the end of
the period and the number of stock options not yet issued but reserved for issuance, if any, all in sufficient detail as to permit the Investors to calculate their respective percentage equity ownership in the Company; and 

(f) such other information relating to the financial condition, business, prospects, or corporate affairs of the Company as any Investor may
from time to time reasonably request; provided, however, that the Company shall not be obligated under this Subsection 3.1 to provide information (i) that the Company reasonably determines in good faith to be a trade secret
or confidential information (unless covered by an enforceable confidentiality agreement, in a form acceptable to the Company); (ii) the disclosure of which would adversely affect the attorney-client privilege between the Company (or the Bank)
and its counsel; or (iii) that would involve the unauthorized disclosure of confidential supervisory information. 
 If, for any
period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating
financial statements of the Company and all such consolidated subsidiaries. 
 Notwithstanding anything else in this Subsection 3.1
to the contrary, the Company may cease providing the information set forth in this Subsection 3.1 during the period starting with the date sixty (60) days before the Company’s good-faith estimate of the date of filing of a
registration statement if it reasonably concludes it must do so to comply with the SEC rules applicable to such registration statement and related offering; provided that the Company’s covenants under this Subsection 3.1 shall be
reinstated at such time as the Company is no longer actively employing its commercially reasonable efforts to cause such registration statement to become effective. 

3.2 Inspection. The Company shall permit each Investor (provided that the Board of Directors has not reasonably determined that
such Investor is a Competitor), at such Investor’s expense, to visit and inspect the Company’s properties; examine its books of account and records; and discuss the Company’s affairs, finances, and accounts with its officers, during
normal business hours of the Company as may be reasonably requested by the Investor and upon reasonable advance notice; provided, however, that the Company shall not be obligated 

  
 17 

 
pursuant to this Subsection 3.2 to provide access to any information that it reasonably and in good faith considers to be a trade secret or confidential information (unless covered by an
enforceable confidentiality agreement, in form acceptable to the Company), which would involve the unauthorized disclosure of confidential supervisory information, or the disclosure of which would adversely affect the attorney-client privilege
between the Company (or the Bank) and its counsel; provided further, that the Company shall not be required to permit Investor inspection pursuant to this Section 3.2 more frequently than once per quarter. 

3.3 Observer Rights. The Company shall invite a representative (who shall initially be Robert Patten) of Wellington Management
Company, LLP, on behalf of the Investors, to attend all meetings of the Board of Directors of each of the Company and the Bank and the committees thereof in a nonvoting observer capacity and, in this respect, shall give such representative copies of
all notices, minutes, consents, and other materials that the Company and the Bank provide to their respective directors at the same time and in the same manner as provided to such directors; provided, however, that such representative
shall agree to hold in confidence and trust all information so provided; and provided further, that the Company (on its behalf and on behalf of the Bank) reserves the right to withhold any information and to exclude such representative
from any meeting or portion thereof if access to such information or attendance at such meeting would (i) adversely affect the attorney-client privilege between the Company (or the Bank) and its counsel, (ii) result in disclosure of trade
secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company (or the Bank) or (iii) involve the unauthorized disclosure of confidential supervisory information. 

3.4 Termination of Information and Observer Rights. The covenants set forth in Subsection 3.1, Subsection 3.2, and
Subsection 3.3 shall terminate and be of no further force or effect (i) immediately before the consummation of the IPO, or (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or
15(d) of the Exchange Act. 
 3.5 Confidentiality. Each Investor agrees that such Investor will keep confidential and will not
disclose, divulge, or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the Company’s intention to file
a registration statement), unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Subsection 3.5 by such Investor), (b) is or has been independently
developed or conceived by the Investor without use of the Company’s confidential information, or (c) is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of confidentiality such third
party may have to the Company; provided, however, that an Investor may disclose confidential information (i) to its attorneys, accountants, consultants, investment advisers, custodians and other professionals to the extent
necessary to obtain their services in connection with monitoring its investment in the Company so long as such Person agrees to keep such information confidential or is bound by professional duties obligating such Person to hold such information in
confidence; (ii) to any prospective purchaser of any Registrable Securities from such Investor, if such prospective purchaser agrees to be bound by the provisions of this Subsection 3.5; (iii) to any equityholder of such Investor in the
ordinary course of business, provided that such Investor informs such Person 

  
 18 

 
that such information is confidential and directs such Person to maintain the confidentiality of such information; or (iv) as may otherwise be required by, or requested under, law,
regulation, the rules of any court, or governmental organization or agency, or the requirements of any stock exchange or other regulatory organization, with whose rules Investor are required to comply, or by legal process, provided, in the case of
clauses (i) through (iii), that the Investor shall be responsible for any disclosure of such confidential information by any such Person as though such inappropriate disclosure were made by such Investor in violation of this Subsection 3.5 and,
in the case of clause (iv), that the Investor promptly notifies the Company of such disclosure, to the extent permissible, and takes reasonable steps to minimize the extent of any such disclosure. Furthermore, the provisions of this Subsection
3.5 shall supersede and replace that certain Confidentiality Agreement, by and between the Company and Wellington Management Company, LLP, dated February 19, 2014 (the “Confidentiality Agreement”), and the Confidentiality Agreement
shall be deemed terminated upon the effectiveness hereof. 
 4. Rights to Future Stock Issuances. 

4.1 Right of Participation. Subject to the terms and conditions of this Subsection 4.1 and applicable securities laws, if the
Company proposes to offer or sell any New Securities, the Company shall allow each Investor to purchase a portion of such New Securities to the extent set forth in Subsection 4.1 (b). An Investor shall be entitled to apportion the right of
first offer hereby granted to it in such proportions as it deems appropriate, among (i) itself, (ii) its Affiliates and (iii) its beneficial interest holders, such as limited partners, members or any other Person having
“beneficial ownership,” as such term is defined in Rule 13d-3 promulgated under the Exchange Act, of such Investor (“Investor Beneficial Owners”); provided that each such Affiliate or Investor Beneficial Owner
(x) is not a Competitor, unless such party’s purchase of New Securities is otherwise consented to by the Board of Directors, and (y) agrees to enter into, at the time any New Securities are acquired by such Person, this Agreement and
the Right of Co-Sale and Voting Agreement of even date herewith among the Company, the Investors and the other parties named therein (the “Co-Sale Agreement”) as an “Investor”
and “Holder” under each such agreement (provided that any Competitor shall not be entitled to any rights as an Investor under Subsections 3.1, 3.2 and 4.1 hereof). 

(a) In the event the Company proposes to issue any New Securities, the Company shall give notice (the “Offer Notice”) to
each Investor, stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and material terms, if any, upon which it proposes to offer such New
Securities. 
 (b) By written notification to the Company within fifteen (15) days after the Offer Notice is given, each Investor
may elect to purchase, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities that equals the proportion that the Common Stock then held by such Investor (including all shares of Common Stock then
issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of any Derivative Securities then held by such Investor) bears to the total Common Stock of the Company then outstanding (assuming full conversion and/or exercise, as
applicable, of all Derivative Securities). Any Investor that does not provide written notice of election within such fifteen (15) day period shall have no further rights with respect to such issuance of New Securities, At the

  
 19 

 
expiration of such fifteen (15) day period, the Company shall promptly notify each Investor that elected to purchase all the shares available to it (each, a “Fully Exercising
Investor”) of any other Investor’s failure to do likewise. During the five (5) day period commencing after the Company has given such notice, each Fully Exercising Investor may, by giving notice to the Company, elect to purchase
or acquire, in addition to the number of shares specified above, up to that portion of the New Securities for which Investors were entitled to subscribe but that were not subscribed for by the Investors which is equal to the proportion that the
Common Stock issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of any Derivative Securities then held, by such Fully Exercising Investor bears to the Common Stock issued and held, or issuable
(directly or indirectly) upon conversion and/or exercise, as applicable, of any Derivative Securities then held, by all Fully Exercising Investors who wish to purchase such unsubscribed shares. The closing of any sale pursuant to this Subsection
4.1(b) shall occur within the later of ninety (90) days of the date that the Offer Notice is given and the date of initial sale of New Securities pursuant to Subsection 4.1(c). Notwithstanding anything to the contrary set forth
herein, in lieu of New Securities which are voting securities of the Company; an Investor may elect to acquire non-voting securities of the Company with the same rights, preference and terms as such New Securities (other than with respect to
voting). 
 (c) If all New Securities referred to in the Offer Notice are not elected to be purchased or acquired as provided in
Subsection 4.1(b), the Company may, during the ninety (90) day period following the expiration of the periods provided in Subsection 4.1(b), offer and sell the remaining unsubscribed portion of such New Securities to any Person or
Persons at a price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New Securities within such period, or if such agreement
is not consummated within thirty (30) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Investors in accordance with this
Subsection 4.1. 
 (d) The right of first offer in this Subsection 4.1 shall not be applicable to (i) Exempted
Securities; (ii) shares of Common Stock issued in the IPO; and (iii) in connection with any expedited issuance of New Securities undertaken at the written direction of an applicable bank regulatory authority (an “Expedited
Issuance”); provided that following consummation of such Expedited Issuance, the Company shall then comply with the provisions of this Section 4.1 and allow each Investor to purchase up to that number of additional New Securities to enable
such Investor to maintain its percentage interest in the Company (calculated as of immediately prior to such Expedited Issuance), and the sale of any such additional New Securities to the Investors shall be consummated as promptly as is practicable
but in any event no later than ninety (90) days subsequent to the date on which the Company consummates the Expedited Issuance. 
 4.2
Termination. The covenants set forth in Subsection 4.1 shall terminate and be of no further force or effect immediately before the consummation of the IPO. 

  
 20 

 5. Additional Covenants. 

5.1 Insurance. The Company shall use its commercially reasonable efforts to maintain following the date hereof, from financially sound
and reputable insurers (i) Directors and Officers liability insurance (for both the Company and the Bank) in an amount and on terms and conditions satisfactory to the Board of Directors of the Company and (ii) term “key-person”
insurance on each of James S. Mahan III and Neil L. Underwood in an amount of at least $18 million and $4 million, respectively, provided that the Company shall use commercially reasonable efforts to increase such amounts, within sixty
(60) days of the date hereof, to $30 million and $10 million, respectively. The Company will use commercially reasonable efforts to cause such Directors and Officers liability insurance policy to be maintained until such time as the Board of
Directors determines that such insurance should be discontinued. The Company will use commercially reasonable efforts to cause such “key person” insurance policy to be maintained until such time as the holders of a majority of the
Registrable Securities determine that such insurance should be discontinued. The key-person policy shall name the Company as loss payee. 

5.2 Employee Agreements. The Company will cause each person now or hereafter employed by it or by any of its subsidiaries (or engaged
by the Company or any of its subsidiaries as a consultant/independent contractor) with access to confidential information and/or trade secrets of the Company or any of its subsidiaries to enter into a nondisclosure and proprietary rights assignment
agreement. 
 5.3 Employee Stock. Unless otherwise approved by the Board of Directors, all future employees and consultants of the
Company who purchase, receive options to purchase, or receive awards of shares of the Company’s capital stock after the date hereof shall be required to execute restricted stock or option agreements, as applicable, providing for
(i) vesting of shares over a seven (7) year period, with 10% vesting on each of the first five anniversaries of the date of grant and 25% vesting on each of the sixth and seventh anniversaries of the date of grant, and (ii) a market
stand-off provision substantially similar to that in Subsection 2.11. In addition, unless otherwise approved by the Board of Directors, the Company shall retain a “right of first refusal” on employee transfers until the
Company’s IPO and shall have the right to repurchase unvested shares at cost upon termination of employment of a holder of restricted stock. 

5.4 Board Approval of Significant Corporate Matters. The Company hereby covenants and agrees with each of the Investors that it shall
not, either directly or indirectly by amendment, merger, consolidation or otherwise, do any of the following without approval of the Board of Directors of the Company, which approval must include the affirmative vote of at least a majority of the
Non-Management Directors: 
 (a) (i) liquidate, dissolve or wind-up the business and affairs of the Company or the Bank, (ii) or
effect any merger, consolidation, sale or any other change of control transaction of the Company or the Bank (including, without limitation, a Sale of the Company), or (iii) consent to any of the foregoing; 

  
 21 

 (b) amend, alter or repeal any provision of the charter or bylaws of the Company or the Bank;

 (c) create, or authorize the creation of, or issue or obligate itself to issue shares of, any additional class or series of capital
stock unless the same ranks on parity with, or junior to, the Common Stock, including, without limitation, with respect to the distribution of assets on the liquidation, dissolution or winding up of the Company and the payment of dividends, or
increase the authorized number of shares of any additional class or series of capital stock unless the same ranks on parity with, or junior to, the Common Stock, including, without limitation, with respect to the distribution of assets on the
liquidation, dissolution or winding up of the Company, the payment of dividends and rights of redemption; 
 (d) purchase or redeem (or
permit any subsidiary to purchase or redeem) or pay or declare any dividend or make any distribution on any shares of capital stock of the Company other than (i) dividends or other distributions payable on the Common Stock solely in the form of
additional shares of Common Stock, (ii) repurchases of stock from former employees, officers, directors, consultants or other persons who performed services for the Company or any subsidiary in connection with the cessation of such employment
or service at the lower of the original purchase price or the then-current fair market value thereof and (iii) purchases made pursuant to that certain Amended and Restated Shareholders Agreement, by and among the Company and the shareholders of
the Company party thereto, dated as of the date hereof, as amended from time to time; or 
 (e) establish any new equity incentive plan or
allow for more than 192,667 shares (including 166,667 shares underlying outstanding stock options), in the aggregate, to be issued under the Company’s existing equity incentive plans. 

5.5 Board Matters. Unless otherwise determined by the vote of a majority of the directors then in office, the Board of Directors of
each of the Company and the Bank shall meet at least quarterly in accordance with an agreed-upon schedule. The Company and the Bank, as applicable, shall reimburse the Non-Management Directors for all reasonable out-of-pocket travel expenses
incurred (consistent with their respective travel policies) in connection with attending meetings of their respective Board of Directors. 

5.6 Successor Indemnification. If the Company or any of its successors or assignees consolidates with or merges into any other Person
and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be made so that the successors and assignees of the Company assume the obligations of the Company with
respect to indemnification of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are contained in the Company’s Bylaws, its Articles of Incorporation, or elsewhere, as the case may be.

 5.7 FCPA. The Company shall not (and shall not knowingly permit any of its subsidiaries or affiliates or any of its or their
respective directors, officers, managers, employees, independent contractors, representatives or agents to) promise, authorize or make any 

  
 22 

 
payment to, or otherwise contribute any item of value to, directly or indirectly, any third party, including any Non-U.S. Official (as such term is defined in the U.S. Foreign Corrupt Practices
Act of 1977, as amended (the “FCPA”)), in each case in violation of the FCPA, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law. The Company shall (and shall cause each of its subsidiaries and
affiliates to) cease all of its or their respective activities, as well as remediate any actions known to have been taken by the Company, its subsidiaries or affiliates, or any of their respective directors, officers, managers, employees,
independent contractors, representatives or agents in violation of the FCPA, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law. The Company shall (and shall cause each of its subsidiaries and affiliates to) maintain
systems of internal controls (including, but not limited to, accounting systems, purchasing systems and billing systems) to ensure compliance with the FCPA, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law. 

5.8 Termination of Covenants. The covenants set forth in this Section 5, except for Subsection 5.6, shall terminate and be
of no further force or effect (i) immediately before the consummation of the IPO or (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act. 

6. Miscellaneous. 
 6.1
Successors and Assigns. The rights under this Agreement may be assigned (but only with all related obligations) by a Holder to a transferee of Registrable Securities that (i) is an Affiliate of a Holder and not a Competitor or
(ii) after such transfer, holds at least 25,000 shares of Registrable Securities (subject to appropriate adjustment for stock splits, stock dividends, combinations and other recapitalizations); provided, however, that (x) the
Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee and the Registrable Securities with respect to which such rights are being transferred; and (y) such transferee
agrees in a written instrument delivered to the Company at the time of such transfer to be bound by and subject to the terms and conditions of this Agreement, including the provisions of Subsection 2.11. For the purposes of determining the
number of shares of Registrable Securities held by a transferee, the holdings of a transferee that is an Affiliate of a Holder shall be aggregated together with those of the transferring Holder; provided further that all transferees
who would not qualify individually for assignment of rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices, or taking any action under this Agreement. The terms and conditions of this Agreement inure
to the benefit of and are binding upon the respective successors and permitted assignees of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors
and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided herein. 

6.2 Governing Law. This Agreement shall be governed by the internal law of the State of New York. 

6.3 Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute 

  
 23 

 
one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000,
e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

6.4 Titles and Subtitles. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in
construing or interpreting this Agreement. 
 6.5 Notices. All notices and other communications given or made pursuant to this
Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail or facsimile during the
recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt requested,
postage prepaid; or (iv) one (1) business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery, with written verification of receipt. All communications shall
be sent to the respective parties at their addresses as set forth on Schedule A hereto, or to the principal office of the Company and to the attention of the Chief Executive Officer, in the case of the Company, or to such email address,
facsimile number, or address as subsequently modified by written notice given in accordance with this Subsection 6.5. If notice is given to the Company, a copy (which shall not constitute notice) shall also be sent to Wyrick Robbins
Yates & Ponton LLP, 4101 Lake Boone Trail, Suite 300, Raleigh, NC 27607, Attn: Todd H. Eveson, telephone: (919) 781-4000, fax: (919) 781-4865, email: teveson@wyrick.com, and if notice is given to the Investors, a copy
(which shall not constitute notice) shall also be given to Greenberg Traurig, LLP, One International Place, Boston, MA 02110, Attn: Bradley A. Jacobson, telephone: (617) 310-6000, fax: (617) 279-8402, e-mail: jacobsonb@gt1aw.com.

 6.6 Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be
waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Company and the holders of a majority of the Registrable Securities then outstanding; provided that the
Company may in its sole discretion waive compliance with Subsection 2.12(c); provided further that any provision hereof may be waived by any waiving party on such party’s own behalf, without the consent of any other party.
Notwithstanding the foregoing, this Agreement may not be amended or terminated and the observance of any term hereof may not be waived with respect to any Investor without the written consent of such Investor, unless such amendment, termination, or
waiver applies to all Investors in the same fashion (it being agreed that a waiver of the provisions of Section 4 with respect to a particular transaction shall be deemed to apply to all Investors in the same fashion if such waiver does
so by its terms, notwithstanding the fact that certain Investors may nonetheless, by agreement with the Company, purchase securities in such transaction). The Company shall give prompt notice of any amendment or termination hereof to any party
hereto that did not consent in writing to such amendment or termination. Any amendment, termination, or waiver effected in accordance with this Subsection 6.6 shall be binding on all parties hereto, regardless of whether any such party has
consented thereto. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision. 

  
 24 

 6.7 Severability. In case any one or more of the provisions contained in this Agreement
is for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be
reformed and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law. 
 6.8 Entire
Agreement. This Agreement (including any Schedules and Exhibits hereto) constitutes the full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to
the subject matter hereof existing between the parties is expressly canceled. 
 6.9 Dispute Resolution. Each party agrees that all
Proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (as defined in the Purchase Agreement) (whether brought against a party hereto or its
respective Affiliates, employees or agents) may be commenced on a non-exclusive basis in the New York Courts (as defined in the Purchase Agreement). Each party hereto hereby irrevocably submits to the non-exclusive jurisdiction of the New York
Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such New York Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby
irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in
effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY. 
 6.10 Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any
party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or acquiescence to
any such breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All remedies, whether
under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative. 

  
 25 

 6.11 Acknowledgment. The Company acknowledges that the Investors and/or such
Investors’ investment advisers are in the business of making, selecting and/or managing venture capital and other investments and therefore review the business plans and related proprietary information of many enterprises, including enterprises
which may have products or services which compete directly or indirectly with those of the Company. Nothing in this Agreement shall preclude or in any way restrict the Investors and/or such Investors’ investment advisers from investing or
participating in any particular enterprise whether or not such enterprise has products or services which compete with those of the Company. 

6.12 No Association. Each of the parties acknowledges, represents, warrants and agrees that this Agreement (i) relates only to
the shares of capital stock of the Company, (ii) will terminate no later than the twentieth (20th) anniversary of the date of this Agreement, and (iii) does not create an association among the parties to engage in activities other
than through the Company. 
 [Remainder of Page Intentionally Left Blank] 

  
 26 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

					
	LIVE OAK BANCSHARES, INC.
			
	By:		    		

					  

	Name:				James S. Mahan, III
	Title:				Chairman & Chief Executive Officer
	
	INVESTORS:
	
	For and on behalf of each of the entities listed on Schedule A hereto, individually and not jointly and severally
			
	By:				Wellington Management Company, LLP, as investment adviser
			
	By:				

					  

	Name:				Steven M. Hoffman
	Title:				Vice President and Counsel

 SCHEDULE A 

Investors 
 Legal Entity Name and
Address 
 Bay Pond Investors USB, LLC 
 c/o
Wellington Management Company LLP 
 Attention: Steven M. Hoffman 

280 Congress Street 
 Boston, Massachusetts 02210 

Facsimile Number: 617-289-5699 
 Email address:
seclaw@wellington.com 
 Bay Pond Partners, L.P. 

c/o Wellington Management Company LLP 
 Attention: Steven M.
Hoffman 
 280 Congress Street 
 Boston, Massachusetts 02210

 Facsimile Number: 617-289-5699 
 Email address:
seclaw@wellington.com 
 Ithan Creek Investors USB, LLC 

c/o Wellington Management Company LLP 
 Attention: Steven M.
Hoffman 
 280 Congress Street 
 Boston, Massachusetts 02210

 Facsimile Number: 617-289-5699 
 Email address:
seclaw@wellington.com 
 Wolf Creek Investors USB, LLC 

c/o Wellington Management Company LLP 
 Attention: Steven M.
Hoffman 
 280 Congress Street 
 Boston, Massachusetts 02210

 Telephone Number: 617-790-7770 
 Facsimile Number:
617-289-5699 
 Email address: seclaw@wellington.com 

Wolf Creek Partners, L.P. 
 c/o Wellington Management
Company LLP 
 Attention: Steven M, Hoffman 
 280 Congress
Street 
 Boston, Massachusetts 02210 
 Facsimile Number:
617-289-5699 
 Email address: seclaw@wellington.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}]]